Literature DB >> 26526580

Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.

Flavio Mavignier Cárcano1,2, Daniel Onofre Vidal3,4, André van Helvoort Lengert3,4, Cristovam Scapulatempo Neto3,5, Luisa Queiroz6, Herlander Marques6, Fátima Baltazar7,8, Camila Maria da Silva Martinelli3, Paula Soares9,10,11, Eduardo Caetano Albino da Silva5, Luiz Fernando Lopes12,13, Rui Manuel Reis14,15,16.   

Abstract

The abnormal activation of telomerase, codified by the telomerase reverse transcriptase (TERT) gene, is related to one of cancer hallmarks. Hotspot somatic mutations in the promoter region of TERT, specifically the c.-124:C>T and c.-146:C>T, were recently identified in a range of human cancers and have been associated with a more aggressive behavior. Testicular germ cell tumors frequently exhibit a good prognosis; however, the development of refractory disease is still a clinical challenge. In this study, we aim to evaluate for the first time the presence of the hotspot telomerase reverse transcriptase gene promoter mutations in testicular germ cell tumors. A series of 150 testicular germ cell tumor cases and four germ cell tumor cell lines were evaluated by PCR followed by direct Sanger sequencing and correlated with patient's clinical pathological features. Additionally, we genotyped the telomerase reverse transcriptase gene promoter single nucleotide polymorphism rs2853669 (T>C) located at -245 position. We observed the presence of the TERT promoter mutation in four patients, one exhibited the c.-124:C>T and three the c.-146:C>T. No association between TERT mutation status and clinicopathological features could be identified. The analysis of the rs2853669 showed that variant C was present in 22.8 % of the cases. In conclusion, we showed for the first time that TERT promoter mutations occur in a small subset (~3 %) of testicular germ cell tumors.

Entities:  

Keywords:  Mutation; Neoplasms, germ cell, and embryonal; Polymorphism, single nucleotide; TERT protein; Testicular neoplasms

Mesh:

Substances:

Year:  2015        PMID: 26526580     DOI: 10.1007/s13277-015-4317-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

Review 1.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

2.  TERT promoter mutations in clear cell renal cell carcinoma.

Authors:  Ismail Hosen; P Sivaramakrishna Rachakonda; Barbara Heidenreich; Raviprakash T Sitaram; Börje Ljungberg; Göran Roos; Kari Hemminki; Rajiv Kumar
Journal:  Int J Cancer       Date:  2014-10-30       Impact factor: 7.396

Review 3.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

4.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

5.  Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors.

Authors:  R Nowak; K Sikora; A Pietas; I Skoneczna; S J Chrapusta
Journal:  Oncogene       Date:  2000-08-17       Impact factor: 9.867

6.  Treatment of testicular cancer: a new and improved model.

Authors:  L H Einhorn
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

7.  Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.

Authors:  Mark Schrader; Angelika M Burger; Markus Müller; Hans Krause; Bernd Straub; Gilian L Smith; Eward S Newlands; Kurt Miller
Journal:  Oncol Rep       Date:  2002 Sep-Oct       Impact factor: 3.906

8.  Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91.

Authors:  Luiz Fernando Lopes; Carla Renata Pacheco Macedo; Elitânia Marinho Pontes; Simone Dos Santos Aguiar; Maria José Mastellaro; Renato Melaragno; Sonia Maria Rossi Vianna; Paula Azevedo Allemand Lopes; Nubia Mendonça; Maria Teresa de Assis Almeida; Viviane Sonaglio; Karina B Ribeiro; Victor M Santana; Dominik T Schneider; Beatriz de Camargo
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544

9.  Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells.

Authors:  Susanna Dolci; Lauretta Levati; Manuela Pellegrini; Isabella Faraoni; Grazia Graziani; Anna Di Carlo; Raffaele Geremia
Journal:  J Cell Sci       Date:  2002-04-15       Impact factor: 5.285

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  7 in total

Review 1.  Understanding TERT Promoter Mutations: A Common Path to Immortality.

Authors:  Robert J A Bell; H Tomas Rube; Ana Xavier-Magalhães; Bruno M Costa; Andrew Mancini; Jun S Song; Joseph F Costello
Journal:  Mol Cancer Res       Date:  2016-03-03       Impact factor: 5.852

Review 2.  Telomerase: The Devil Inside.

Authors:  Mukesh Kumar; Andre Lechel; Çagatay Güneş
Journal:  Genes (Basel)       Date:  2016-07-29       Impact factor: 4.096

3.  HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.

Authors:  TingDong Yan; Wen Fong Ooi; Aditi Qamra; Alice Cheung; DongLiang Ma; Gopinath Meenakshi Sundaram; Chang Xu; Manjie Xing; LaiFong Poon; Jing Wang; Yan Ping Loh; Jess Hui Jie Ho; Joscelyn Jun Quan Ng; Muhammad Khairul Ramlee; Luay Aswad; Steve G Rozen; Sujoy Ghosh; Frederic A Bard; Prabha Sampath; Vinay Tergaonkar; James O J Davies; Jim R Hughes; Eyleen Goh; Xuezhi Bi; Melissa Jane Fullwood; Patrick Tan; Shang Li
Journal:  Nat Commun       Date:  2018-01-08       Impact factor: 14.919

Review 4.  TERT-Regulation and Roles in Cancer Formation.

Authors:  Marta Dratwa; Barbara Wysoczańska; Piotr Łacina; Tomasz Kubik; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

Review 5.  Molecular Biology of Pediatric and Adult Male Germ Cell Tumors.

Authors:  Mariana Tomazini Pinto; Flavio Mavignier Cárcano; Ana Glenda Santarosa Vieira; Eduardo Ramos Martins Cabral; Luiz Fernando Lopes
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

Review 6.  Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

Authors:  Muhammad Khairul Ramlee; Jing Wang; Wei Xun Toh; Shang Li
Journal:  Genes (Basel)       Date:  2016-08-18       Impact factor: 4.096

Review 7.  Telomere Maintenance in Pediatric Cancer.

Authors:  Sandra Ackermann; Matthias Fischer
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.